IP Library Granted Patent US 7,371,409
Granted Patent B2
US 7,371,409 · App. 09/947,833 · Granted May 13, 2008

Bone graft substitute composition

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,371,409
App. No.
09/947,833
Granted
May 13, 2008
Kind
B2
Abstract

A bone graft substitute composition can include essentially of calcium sulfate, a mixing solution, and a plasticizing substance. A bone graft substitute composition can include calcium sulfate, demineralized bone matrix, cancellous bone, a plasticizing substance, and a mixing solution.

Claims (85)

1. A bone graft substitute composition, comprising:

about 80 to about 120 parts by weight of calcium sulfate;

about 10 to about 100 parts by weight of demineralized bone matrix;

about 20 to about 130 parts by weight of cancellous bone;

about 1 to about 40 parts by weight of a plasticizing substance; and

about 21 to about 250 parts by weight of a mixing solution, wherein the cancellous bone has a particle size between about 1 and about 4 mm.

2. The composition of claim 1 , wherein the calcium sulfate comprises calcium sulfate hemihydrate.

3. The composition of claim 1 , wherein the plasticizing substance comprises a cellulose derivative.

4. The composition of claim 1 , wherein the plasticizing substance is selected from a group consisting of sodium carboxymethylcellulose, methylcellulose, hydroxypropyl methyl cellulose, hydroxypropyl cellulose, ethylcellulose, hydroxyethylcellulose, and cellulose acetate butyrate.

5. The composition of claim 1 , wherein the mixing solution is selected from a group consisting of sterile water, inorganic salt, and cationic surface active agent.

6. The composition of claim 5 , wherein the cationic surface active agent is selected from a group consisting of sodium chloride, phosphate buffered saline, potassium chloride, sodium sulfate, ammonium sulfate, ammonium acetate, and sodium acetate.

7. The composition of claim 1 , wherein the mixing solution comprises sterile water.

8. The composition of claim 1 , wherein the mixing solution comprises a material selected from a group consisting of bone marrow aspirate, platelet concentrate, blood, an antibiotic, a chemotherapeutic agent, a growth factor, and an analgesic.

9. The composition of claim 1 , comprising:

about 90 to about 110 parts by weight of calcium sulfate;

about 10 to about 50 parts by weight of demineralized bone matrix;

about 15 to about 50 parts by weight of cancellous bone;

about 5 to about 20 parts by weight of a plasticizing substance; and

about 80 to about 120 parts by weight of a mixing solution.

10. The composition of claim 1 , comprising:

about 98 to about 102 parts by weight of calcium sulfate;

about 13 to about 23 parts by weight of demineralized bone matrix;

about 37 to about 46 parts by weight of cancellous bone;

about 15 to about 20 parts by weight of a plasticizing substance; and

about 95 to about 105 parts by weight of a mixing solution.

11. The composition of claim 1 , comprising:

about 100 parts by weight of calcium sulfate;

about 18 to about 19 parts by weight of demineralized bone matrix;

about 40 to about 42 parts by weight of cancellous bone;

about 17 to about 18 parts by weight of a plasticizing substance; and

about 101 to about 102 parts by weight of a mixing solution.

12. A bone graft substitute composition, comprising: about 80 to about 120 parts by weight of calcium sulfate;

about 10 to about 120 parts by weight of demineralized bone matrix;

about 20 to about 150 parts by weight of cancellous bone;

about 1 to about 40 parts by weight of a plasticizing substance; and

about 50 to about 300 parts by weight of a mixing solution, wherein the cancellous bone has a particle size between about 4 and about 10 mm.

13. The composition of claim 12 , wherein the calcium sulfate comprises calcium sulfate hemihydrate.

14. The composition of claim 12 , wherein the plasticizing substance comprises a cellulose derivative.

15. The composition of claim 12 , wherein the plasticizing substance is selected from a group consisting of sodium carboxymethylcellulose, methylcellulose, hydroxypropyl methyl cellulose, hydroxypropyl cellulose, ethylcellulose, hydroxyethylcellulose, and cellulose acetate butyrate.

16. The composition of claim 12 , wherein the mixing solution is selected from a group consisting of sterile water, inorganic salt, and cationic surface active agent.

17. The composition of claim 16 , wherein the cationic surface active agent is selected from a group consisting of sodium chloride, phosphate buffered saline, potassium chloride, sodium sulfate, ammonium sulfate, ammonium acetate, and sodium acetate.

18. The composition of claim 12 , wherein the mixing solution comprises sterile water.

19. The composition of claim 12 , wherein the mixing solution comprises a material selected from a group consisting of bone marrow aspirate, platelet concentrate, blood, an antibiotic, a chemotherapeutic agent, a growth factor, and an analgesic.

20. The composition of claim 12 , comprising:

about 90 to about 110 parts by weight of calcium sulfate;

about 10 to about 60 parts by weight of demineralized bone matrix;

about 40 to about 120 parts by weight of cancellous bone;

about 5 to about 20 parts by weight of a plasticizing substance; and

about 140 to about 180 parts by weight of a mixing solution.

21. The composition of claim 12 , comprising:

about 98 to about 102 parts by weight of calcium sulfate;

about 25 to about 35 parts by weight of demineralized bone matrix;

about 44 to about 110 parts by weight of cancellous bone;

about 15 to about 20 parts by weight of a plasticizing substance; and

about 160 to about 170 parts by weight of a mixing solution.

22. The composition of claim 12 , comprising:

about 100 parts by weight of calcium sulfate;

about 30 to about 32 parts by weight of demineralized bone matrix;

about 99 to about 105 parts by weight of cancellous bone;

about 17 to about 18 parts by weight of a plasticizing substance; and

about 162 to about 168 parts by weight of a mixing solution.

23. A kit for making a bone graft substitute composition, the kit comprising:

a first portion comprising:

about 80 to about 120 parts by weight of calcium sulfate;

about 10 to about 120 parts by weight of demineralized bone matrix;

a first portion of cancellous bone having a particle size between about 4 and about 10 mm; and

about 1 to about 40 parts by weight of a plasticizing substance;

a second portion comprising:

a second portion of cancellous bone having a particle size between about 4 and about 10 mm; and

a third portion comprising:

about 50 to about 300 parts by weight of a mixing solution,

wherein the first and second portions of cancellous bone total about 20 to about 150 parts by weight of cancellous bone.

24. The kit of claim 23 , wherein the first portion comprises about 40 to about 50 parts by weight of cancellous bone.

25. A method of preparing a bone graft substitute composition, the method comprising:

providing a first portion comprising:

about 80 to about 120 parts by weight of calcium sulfate;

about 10 to about 120 parts by weight of demineralized bone matrix;

a first portion of cancellous bone having a particle size between about 4 and about 10 mm; and

about 1 to about 40 parts by weight of a plasticizing substance;

providing a second portion comprising:

a second portion of cancellous bone having a particle size between about 4 and about 10 mm, wherein the first and second portions of cancellous bone total about 20 to about 150 parts by weight of cancellous bone;

providing a third portion comprising:

about 50 to about 300 parts by weight of a mixing solution; and

mixing the third portion with the first portion to form a bone graft substitute composition.

26. The method of claim 25 , further comprising mixing a portion of the second portion with the third and first portions.

Assignments (2)
RELEASE OF SECURITY INTEREST Recorded Nov 19, 2020
From: MIDCAP FUNDING IV TRUST
To: SOLANA SURGICAL, LLC; ORTHOPRO, L.L.C.; WRIGHT MEDICAL GROUP N.V.; WRIGHT MEDICAL GROUP, INC.; BIOMIMETIC THERAPEUTICS CANADA, INC.; BIOMIMETIC THERAPEUTICS, LLC; BIOMIMETIC THERAPEUTICS USA, INC.; INBONE TECHNOLOGIES, INC.; ORTHOHELIX SURGICAL DESIGNS, INC.; TORNIER US HOLDINGS, INC.; TORNIER, INC.; TROOPER HOLDINGS INC.; WHITE BOX ORTHOPEDICS, LLC; WRIGHT MEDICAL CAPITAL, INC.; WRIGHT MEDICAL TECHNOLOGY, INC.; WRIGHT MEDICAL GROUP INTELLECTUAL PROPERTY, INC.
Reel/Frame 054480/0001 →
SECURITY INTEREST Recorded Jan 5, 2017
From: WRIGHT MEDICAL TECHNOLOGY, INC.
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 041257/0126 →